Michael Klichinsky

Chief Scientific Officer, Carisma Therapeutics Inc.

Companies

Carisma Therapeutics Inc.Chief Scientific Officer Mar 9, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Carisma Therapeutics Inc.0 shares²Oct 7, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 7, 2025Sold 56,982 shares at $0.25 of Carisma Therapeutics Inc.²
Oct 7, 2025Exercised options 56,982 shares at $0.11 of Carisma Therapeutics Inc.²
Oct 3, 2025Sold 119,347 shares at $0.26 of Carisma Therapeutics Inc.³
Oct 2, 2025Sold 200,000 shares at $0.25 of Carisma Therapeutics Inc.³
Oct 1, 2025Sold 165,000 shares at $0.26 of Carisma Therapeutics Inc.³
Mar 7, 2023Granted 484,347 shares of Carisma Therapeutics Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCarisma Therapeutics Inc., Chief Scientific Officer
2
SEC EDGARCarisma Therapeutics Inc. shares after the filing of Oct 7, 2025
3
SEC EDGARForm 4 filed Oct 3, 2025
4
SEC EDGARForm 4 filed Mar 9, 2023